title: Human pluripotent stem cell-derived cardiomyocyte based models for cardiotoxicity and drug discovery.
authors: a Department of Chemical Engineering and Applied Chemistry , University of Toronto , Toronto , Ontario , Canada.
authors: Yimu
authors: Y
authors: Zhao
authors: a Department of Chemical Engineering and Applied Chemistry , University of Toronto , Toronto , Ontario , Canada.|b Institute of Biomaterials and Biomedical Engineering , University of Toronto , Toronto , Ontario , Canada.
authors: Anastasia
authors: A
authors: Korolj
authors: b Institute of Biomaterials and Biomedical Engineering , University of Toronto , Toronto , Ontario , Canada.|c TARA Biosystems, Inc ., New York , NY , USA.
authors: Nicole
authors: N
authors: Feric
authors: a Department of Chemical Engineering and Applied Chemistry , University of Toronto , Toronto , Ontario , Canada.|b Institute of Biomaterials and Biomedical Engineering , University of Toronto , Toronto , Ontario , Canada.|d Toronto General Research Institute , University Health Network, University of Toronto , Toronto , Ontario , Canada.
authors: Milica
authors: M
authors: Radisic
mesh_terms: D066126:Cardiotoxicity / Q000517:prevention & control*; D015195:Drug Design; D055808:Drug Discovery / Q000379:methods*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000175:diagnosis / Q000517:prevention & control; D006801:Humans; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000187:drug effects; D039904:Pluripotent Stem Cells / Q000166:cytology*
keywords: Cardiomyocyte; cardiotoxicity; drug discovery; engineered cardiac tissue; high throughput screening; human pluripotent stem cells